NCT01768962 - Tenofovir Levels Following Local Application of Tenofovir Reduced-Glycerin 1% Gel | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

April 30, 2014

Primary Completion Date

December 31, 2014

Study Completion Date

December 31, 2014

Conditions

HIV Prevention

Interventions

DRUG

Once Daily Application of TFV RG 1% Gel - Vaginal

Vaginal application

DRUG

Once Daily Application of TFV RG 1% gel - Rectal

Rectal application

DRUG

Once Daily Application of TFV RG 1% gel - Rectal

Rectal application

DRUG

Once Daily Application of TFV RG 1% Gel - Vaginal

Vaginal application

Trial Locations (1)

Center for Infectious Disease Epidemiologic Research, Mailman School of Public Health, Columbia University, New York

All Listed Sponsors

collaborator

National Institute of Allergy and Infectious Diseases (NIAID)

NIH

collaborator

Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)

NIH

collaborator

National Institute of Mental Health (NIMH)

NIH

lead

CONRAD

OTHER